Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
Drug:  CDKs/JAK2/FLT3 inhibitor TG02 citrate
Find trials that include:  Any drugs shown
Results 1-1 of 1 for your search:
Start Over
Phase 1 Study of TG02 Citrate in Patients With Advanced Hematological Malignancies
Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: TG02-101, NCI-2010-02048, NCT01204164
Start Over